Did You Know...
...In 1790, the cost to obtain a patent was between $4 and $5.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 8115001 | Zeolite ITQ-30 The invention relates to a laminar microporous crystalline zeolite material known as ITQ-30 which, as when synthesized, has a chemical composition in the anhydrous state with the following molar relations: x (M1/n XO2):y YO2:SiO... | 02/14/2012 |
| 8088922 | Dibenzorylenetetracarboximides as infrared absorbers Dibenzorylenetetracarboximides of the general formula I in which the variables are each defined as follows: R′ are identical or different radicals: hydrogen; optionally substituted arylox... | 01/03/2012 |
| 8084610 | Compositions and methods for detecting and treating tumors containing acidic areas Improved compositions have been developed which are selectively sequestered in acidic areas of tumors. When the compositions contain a radioisotope effective to report the presence of the composition, the compositions are useful for detecting tumors. When the compos... | 12/27/2011 |
| 8071775 | Substituted rylene derivatives Rylene derivatives of the general formula I in which the variables are each defined as follows: Rylene is a polycyclic conjugated ring system which comprises at least one perylene unit | 12/06/2011 |
| 7741487 | Method for producing quaterrylene-3,4:13, 14-tetracarboxy diimides by direct synthesis A process for preparing quaterrylene-3,4:13,14-tetracarboximides of the general formula I in which R, R′ are each independently hydrogen or optionally substituted C1-C30-alkyl, C5 | 06/22/2010 |
| 7619086 | HIV integrase inhibitors Compounds of Formula I are inhibitors of HIV integrase and inhibitors of HIV replication: wherein Z, R1, R2, R3, R4, R5, R6, R7, R8 and... | 11/17/2009 |
| 7521556 | 1,6,9,14-tetrasubstituted terrylene tetracarboxylic acid diimides 1,6,9,14-Tetrasubstituted terrylenetetracarboxylic diimides are particularly useful for absorbing and emitting in the long-wavelength red and near infrared region of the electromagnetic spectrum. ... | 04/21/2009 |
| 7427693 | Polar liquid crystal Compounds that are useful in compositions for flat panel displays, for example, are provided. The compounds provided are polar, and are useful in low threshold voltage mixtures. The compounds provided have the general structure: CpCOCH2[A] | 09/23/2008 |
| 7408061 | Rylene dyes Rylene dyes of the general formula I where the variables are defined as follows: R is hydrogen; optionally substituted C1-C30-alkyl, C5-C8-cyclo... | 08/05/2008 |
| 7358362 | Method for the production of terylene-3,4:11,12-tetracarboxydiimides by direct synthesis A process for preparing terylene-3,4:11,12-tetracarboximides I where the variables are each defined as follows: R, R′ are each independently hydrogen; if desired substituted alkyl or cyc... | 04/15/2008 |
| 7273938 | Preparation of novel substituted haloarene compounds This invention relates to a new process for the preparation of novel substituted haloarene compounds of the formula I or IV: respectively, wherein R1, R2, R3, R4, R | 09/25/2007 |
| 7265226 | 1-alkyl-4-(3-substitutedphenyl)piperidines 8-Substituted-2,6-methano-3-benzazocines of general structure I in which A is —CH2—OH, —CH2NH2, —NHSO2CH3, and Y is O, S or NOH are useful ... | 09/04/2007 |
| 7262298 | 4-hydroxybenzomorphans 4-Hydroxybenzomorphans containing carboxamide or thiocarboxamide at the 3-position are useful as analgesics, anti-diarrheal agents, anticonvulsants, antitussives and anti-addiction medications. ... | 08/28/2007 |
| 7253319 | Disubstituted chalcone oximes having RARγ retinoid receptor antagonist activity Compounds of the formula where the variables have the values described in the specification are antagonists of RARγ retinoid receptors. ... | 08/07/2007 |
| 7232829 | Therapeutic compounds and methods The invention provides kappa receptor agonists of formula (I) and delta receptor antagonists of formula (II), wherein R1–R6 X and n have any of the meanings given in the specification, as well as compositions comprising them, methods for thei... | 06/19/2007 |
| 7223864 | 2-hydroxyethidium, methods of preparation and uses thereof The inventors have purified the fluorescent product in the hydroethidine-based supeorxide detection assays and further identified the product as 2-hydroxyethidium. Methods for synthesizing 2-hydroxyethidium and for detecting and quantifying superoxide are provided. | 05/29/2007 |
| 7220856 | Substituted quinoline CCR5 receptor antagonists The present invention relates to CCR5 receptor antagonists of formulae (1a) or (1b): enantiomers, diastereomers, salts and solvates thereof wherein R1, R2, R3, R | 05/22/2007 |
| 7196111 | Pyrazolo[1,5a]pyrimidine compounds as antiviral agents The invention relates to the inhibition of hepatitis C virus (HCV) replication. In particular, embodiments of the invention provide compounds and methods for inhibiting HCV RNA-dependent RNA polymerase enzymatic activity. The invention also provides compositions and... | 03/27/2007 |
| 7166726 | Aryl substituted 3,4-dihydroanthracene derivatives having retinoid antagonist or retinoid inverse agonist type biological activity Disclosed herein are compounds of the formula wherein R1 is independently H or alkyl of 1 to 6 carbons; R2 is optional and is defined as lower alkyl of 1 to 6 carbons, F, Cl, Br... | 01/23/2007 |
| 7145010 | Tert-alkylphenoxy-substituted polycyclic compounds Tert-alkylphenoxy-substituted polycyclic compounds of the general formula I where P is a conjugated polycyclic radical which is stable to bases and nucleophiles, optionally bears aryl substituents an... | 12/05/2006 |
| 7138522 | Rylene derivatives and their use as dyes Rylene derivatives of the general formula I where the variables have the following meanings: R is hydrogen or substituted or unsubstituted C1–C30-alkyl, aryl or hetaryl; ... | 11/21/2006 |
| 7033541 | Bicarbonate receptor compounds The present invention relates to compounds and more particularly to compounds which are useful for the determination of bicarbonate and the delivery of bicarbonate to a non-aqueous solution. The invention further relates to an optical sensor for the determination of... | 04/25/2006 |
| 7018840 | Fluorescent metal sensors, and methods of making and using the same The present invention is directed, in part, to fluorescent metal sensors for detecting metal ions, and methods of making and using the same. ... | 03/28/2006 |
| 6890377 | Thermochromic rylene dyes Rylene dyes of the general formula I where R is hydrogen; unsubstituted or substituted C1-C30-alkyl, aryl or hetaryl; R′ is unsubstituted or substituted C2-C... | 05/10/2005 |
| 6881867 | Method for hydroformylation, xanthene-bridged ligands and catalyst comprising a complex of said ligands In a process for the hydroformylation of ethylenically unsaturated compounds, at least one complex of a metal of transition group VIII. with at least one phosphorus-, arsenic- or antimony-containing compound as ligand is used as hydroformylation catalyst, where the ... | 04/19/2005 |
| 6878825 | Rylene derivatives and their use as dyes Rylene derivatives of the general formula I where the variables have the following meanings: R is hydrogen or substituted or unsubstituted C1-C30-alkyl, aryl or ... | 04/12/2005 |
| 6821962 | Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and /or p56lck tyrosine kinases This invention is directed to quinoline/quinoxaline compounds which inhibit platelet-derived growth factor or p56lck tyrosine kinase activity, to pharmaceutical compositions comprising these compounds, and to the use of these compounds for treating a pati... | 11/23/2004 |
| 6818149 | Ligand and complex for catalytically bleaching a substrate The present invention provides a bleaching composition comprising a [3.3.1] bicyclo compound carrying at least one tertiary amine group the bleaching composition substantially devoid of a peroxygen source. ... | 11/16/2004 |
| 6803129 | Organic light emitting diode and organic luminescent materials thereof The present invention relates to an organic light emitting diode (OLED) device, comprising an anode disposed on a substrate, an organic EL layer disposed on the anode and a cathode disposed on the organic EL layer. The material of the organic EL layer comprises a co... | 10/12/2004 |
| 6756497 | Benzoic acid derivatives and processes for the preparation thereof Benzoic acid derivatives useful as intermediates for the preparation of drugs and agricultural chemicals, particularly compounds having herbicidal activity; and easy and economical processes for the preparation of the same. The processes are specifically those repre... | 06/29/2004 |
| 6706698 | α-Substituted β-aminoethyl phosphonate derivatives The present invention relates to novel α-substituted-β-aminoethylphosphonate and α-substituted-β-aminovinylphosphonate derivatives and their uses for lowering plasma levels of apo (a), Lp(a), apo B, apo B associated lipoproteins (low density lipoproteins and ver... | 03/16/2004 |
| 6703504 | Conformationally constrained compounds as dendrimer cores There are provided novel chemical compounds and their uses in the preparation of polymers and oligomers, and the preparation of such compounds. In certain embodiments there are provided dendritic polymers and oligomers, of a type having at least four poly... | 03/09/2004 |
| 6696418 | Somatostatin antagonists and agonists that act at the SST subtype 2 receptor Compounds according to the formula: ##STR1## and pharmaceutically acceptable salts, solvates or hydrates thereof; wherein group Ar is optionally substituted (C6 -C10)aryl or (C1 -C9)heteroaryl; X is a direct lin... | 02/24/2004 |
| 6689770 | Aryl sulfonyls as factor Xa inhibitors The present application describes aryl sulfonyls of formula I: ##STR1## or pharmaceutically acceptable salt or prodrug forms thereof, wherein D, E, and M are defined below, are effective factor Xa inhibitors.... | 02/10/2004 |
| 6673625 | Saccharide sensing molecules having enhanced fluorescent properties The present invention provides formulae for fluorescent compounds that have a number of properties which make them uniquely suited for use in sensors of analytes such as saccharides. The advantageous fluorescent properties include favorable excitation wav... | 01/06/2004 |
| 6667304 | Polycyclic azaindole compounds The invention relates to compound of formula (I): ##STR1## wherein: G1 represents an alkylene chain as defined in the description, A represents ##STR2## R2 and R3 represent hydrogen, alkyl, alkoxy or hydroxy or ... | 12/23/2003 |
| 6608052 | Compounds useful as anti-inflammatory agents Disclosed are novel aromatic compounds of the formula(I) wherein G, E, W, Ar, X, Y and Z. The compounds are useful for treating diseases or pathological conditions involving inflammation such as chronic inflammatory diseases. Also disclosed are pharmaceut... | 08/19/2003 |
| 6566086 | Diagnostic kit for detecting creatine levels Methods for the detection of creatine compound levels in body fluid samples are discussed. Portable kits capable of determining creatine levels using non-invasive and visually detectable methods are also included.... | 05/20/2003 |
| 6518430 | Process for the preparation of 5-(substituted)-10-methoxy-2,2,4-trimethyl-2,5-dihydro-1H-chromeno[3,4-F]q uinolines and derivatives thereof The present invention relates to an efficient process for the preparation of 5-(substituted)-10-methoxy-2,2,4-trimethyl-2,5-dihydro-1H-chromeno[3,4-f]q uinolines.... | 02/11/2003 |
| 6514633 | Light emitting device material, light emitting device using thereof, and amine compound A light emitting device material comprising a compound represented by the following formula (I): ##STR1## wherein R1, R2 and R3, which may be the same or different, each represents an aryl group, a heterocyclic group or an... | 02/04/2003 |
